My bookmarksSign up free
Source

Commission Regulation (EU) 2017/1510 of 30 August 2017 amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (Text with EEA relevance. )

Commission Regulation (EU) 2017/1510 of 30 August 2017 amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (Text with EEA relevance. )

Regulation (EU) 2017/1510 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex.

Article 2

Open ↗

1.   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2.   It shall apply from the date of entry into force, with the exception of: — paragraphs (1), (2) and (3) of the Annex, which shall apply on 1 March 2018, and — paragraph (4)(a) of the Annex which shall apply on 1 March 2018 to the extent that it relates to the following substances: bisphenol A; [phenol, dodecyl-, branched]; [phenol, 2-dodecyl-, branched]; [phenol, 3-dodecyl-, branched]; [phenol, 4-dodecyl-, branched]; [phenol, (tetrapropenyl) derivatives]; chlorophacinone (ISO); coumatetralyl (ISO); difenacoum (ISO); flocoumafen (ISO); disodium octaborate anhydrous; disodium octaborate tetrahydrate; bromadiolone (ISO); difethialone; [perfluorononan-1-oic acid, and its sodium and ammonium salts]; dicyclohexyl phthalate and triflumizole (ISO).

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Annex XVII to Regulation (EC) No 1907/2006 is amended as follows: (1) in Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein: ‘1,2-dichloropropane; propylene dichloride 602-020-00-0 201-152-2 78-87-5   e-glass microfibers of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO 2  50,0-56,0 %, Al 2 O 3  13,0-16,0 %, B 2 O 3  5,8-10,0 %, Na 2 O < 0,6 %, K 2 O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe 2 O 3 < 0,5 %, F 2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).] 014-046-00-4 — —’   (2) in Appendix 4, the following entry is inserted in the table in order of the index number set out therein: ‘3,7-dimethylocta-2,6-dienenitrile 608-067-00-3 225-918-0 5146-66-7’   (3) in Appendix 5, (a) the following entries are inserted in the table in order of the index numbers set out therein: ‘brodifacoum (ISO); 4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin 607-172-00-1 259-980-5 56073-10-0   lead powder; [particle diameter < 1 mm] 082-013-00-1 231-100-4 7439-92-1   lead massive: [particle diameter ≥ 1 mm] 082-014-00-7 231-100-4 7439-92-1’   (b) the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry: ‘warfarin (ISO); 4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1] (S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2] (R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3] 607-056-00-0 201-377-6 [1] 226-907-3 [2] 226-908-9 [3] 81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3]’   (4) in Appendix 6, (a) the following entries are inserted in the table in order of the index numbers set out therein: ‘tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol 603-061-00-7 202-625-6 97-99-4   gallium arsenide 031-001-00-4 215-114-8 1303-00-0   Tributyltin compounds, with the exception of those specified elsewhere in this Annex 050-008-00-3 — —   1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear 607-710-00-5 271-093-5 68515-50-4   imidazole 613-319-00-0 206-019-2 288-32-4   bisphenol A; 4,4′-isopropylidenediphenol 604-030-00-0 201-245-8 80-05-7   phenol, dodecyl-, branched; [1] phenol, 2-dodecyl-, branched; [2] phenol, 3-dodecyl-, branched; [3] phenol, 4-dodecyl-, branched; [4] phenol, (tetrapropenyl) derivatives [5] 604-092-00-9 310-154-3 [1] - [2] - [3] - [4] - [5] 121158-58-5 [1] - [2] - [3] 210555-94-5 [4] 74499-35-7 [5]   chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione 606-014-00-9 223-003-0 3691-35-8   coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin 607-059-00-7 227-424-0 5836-29-3   difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin 607-157-00-X 259-978-4 56073-07-5   flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin 607-375-00-5 421-960-0 90035-08-8   disodium octaborate anhydrous; [1] disodium octaborate tetrahydrate [2] 005-020-00-3 234-541-0 [1] 234-541-0 [2] 12008-41-2 [1] 12280-03-4 [2]   bromadiolone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2 H -chromen-2-one 607-716-00-8 249-205-9 28772-56-7   difethialone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2 H -1-benzothiopyran-2-one 607-717-00-3 — 104653-34-1   perfluorononan-1-oic acid [1] and its sodium [2] and ammonium [3] salts 607-718-00-9 206-801-3 [1] - [2] - [3] 375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3]   dicyclohexyl phthalate 607-719-00-4 201-545-9 84-61-7   triflumizole (ISO); (1 E )- N -[4-chloro-2-(trifluoromethyl)phenyl]-1-(1 H -imidazol-1-yl)-2-propoxyethanimine 612-289-00-6 — 68694-11-1’   (b) the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl)—2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry: ‘flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione 613-166-00-X — 103361-09-7’

Other acts of the same type
Commission Implementing Regulation (EU) 2025/2156 of 24 October 2025 amending Implementing Regulation (EU) 2025/897 as regards the approval of the listing of ports in accordance with Chapter II of Implementing Regulation (EU) 2024/1474Commission Delegated Regulation (EU) 2026/57 of 24 October 2025 amending Delegated Regulation (EU) 2017/117 as regards conservation measures in the Havet kring Ven site in the Baltic Sea and the correction of a number of errors thereofCouncil Regulation (EU) 2025/2033 of 23 October 2025 amending Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCouncil Implementing Regulation (EU) 2025/2035 of 23 October 2025 implementing Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCouncil Regulation (EU) 2025/2037 of 23 October 2025 amending Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCouncil Implementing Regulation (EU) 2025/2039 of 23 October 2025 implementing Article 8a(1) of Regulation (EC) No 765/2006 concerning restrictive measures in view of the situation in Belarus and the involvement of Belarus in the Russian aggression against UkraineCouncil Regulation (EU) 2025/2041 of 23 October 2025 amending Regulation (EC) No 765/2006 concerning restrictive measures in view of the situation in Belarus and the involvement of Belarus in the Russian aggression against UkraineCommission Implementing Regulation (EU) 2025/2143 of 23 October 2025 amending Regulation (EU) 2015/340 as regards the introduction of competency-based training and assessment and virtual training of air traffic controllersCommission Implementing Regulation (EU) 2025/2147 of 23 October 2025 amending Implementing Regulation (EU) 2024/493 as regards inclusion of a new exporting producer on the list of other cooperating companiesCommission Implementing Regulation (EU) 2025/2148 of 23 October 2025 correcting Commission Implementing Regulation (EU) 2023/265 imposing a definitive anti-dumping duty on imports of ceramic tiles originating in India and TürkiyeCommission Implementing Regulation (EU) 2025/2155 of 23 October 2025 establishing, pursuant to Regulation (EU) 2024/573 of the European Parliament and of the Council, the detailed arrangements relating to the declaration of conformity and the verification by the independent auditor and repealing Commission Implementing Regulation (EU) 2016/879Commission Implementing Regulation (EU) 2025/2174 of 23 October 2025 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for Canada, the United Kingdom and the United States in the lists of third countries, territories, or zones thereof authorised for the entry into the Union of consignments of poultry and germinal products of poultry, and of fresh meat of poultry and game birds

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next